GE HealthCare Technologies AVS — EBIT decreased by 20.5% to $299.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.6%, from $261.00M to $299.00M. Over 2 years (FY 2022 to FY 2025), AVS — EBIT shows relatively stable performance with a -2.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase reflects improved operational performance and profitability, while a decrease suggests margin compression or declining sales.
Earnings Before Interest and Taxes for the segment, serving as a primary indicator of operational profitability. It meas...
Widely used across all industries to compare the core profitability of different business units or companies.
gehc_segment_avs_ebit| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $307.00M | $307.00M | $307.00M | $307.00M | $254.00M | $257.00M | $255.00M | $232.00M | $374.00M | $261.00M | $267.00M | $271.00M | $376.00M | $299.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -17.3% | +1.2% | -0.8% | -9.0% | +61.2% | -30.2% | +2.3% | +1.5% | +38.7% | -20.5% |
| YoY Change | — | — | — | — | -17.3% | — | — | -8.7% | — | +1.6% | +4.7% | +16.8% | +0.5% | +14.6% |